Gyeongnam Gimhae Special Economic Zone

What Gyeongnam Gimhae Special Economic Zone does

Gyeongnam Gimhae Special Economic Zone (경남김해강소특구) is a government-designated special economic zone in South Korea, established in 2021 and administered under the Ministry of Science and ICT with Gyeongsangnam-do Province as the governing authority. Operating as a public-private partnership with Inje University serving as the technology core institution, the zone covers a designated area of 1.13 km² across Gimhae (Gyeongsangnam-do) and is purpose-built to accelerate Korea's bio/healthcare and life sciences industry through three interconnected sub-zones: an R&D Convergence Zone anchored by Inje University and Baek Hospital, a Technology Commercialization Zone at Golden Root Industrial Complex and Gimhae Life Sciences Center, and an Advanced Hub Zone at Seogimhae General Industrial Complex focused on precision medicine and convergent medical devices.

The zone's core offering is not a product but a curated support platform, branded as "Innopolis" and structured under the "BIG-DREAM Wellbio Medicluster" framework. It delivers application-based programs including innotech company cultivation, startup incubation and discovery, IU clinical support and medical device demonstration (via Baek Hospital's clinical trial center), technology commercialization analysis, and OEM/contract manufacturing linkages. Distribution occurs through direct application to the zone administration and one-stop service centers; marketing is conducted via the official website, YouTube, Facebook, and Twitter/X (@G_innopolis), supplemented by a monthly webzine newsletter.

The revenue model is government-funded rather than commercial: support programs are provided at no direct cost to qualifying companies, with operations sustained by public budget allocations. Customer segments are narrowly defined to life sciences/medical device companies and bio-medical startups operating within the Gimhae regional cluster. No revenue figures, headcount data, funding round history, or management team details are disclosed in the source material. Strategic positioning rests on regulatory designation, geographic co-location of university/hospital/industrial infrastructure, and one-stop clinical-commercialization pathways.

Name

Gyeongnam Gimhae Special Economic Zone

Legal name

경남김해강소특구 (Gyeongnam Gimhae Special Economic Zone)

Website

https://innopolis.inje.ac.kr

Company type

Private

Founded year

2021

Operating status

Operating

Short description

Gyeongnam Gimhae Special Economic Zone is a government-designated Korean economic zone, founded 2021, that supports life sciences and medical device companies through R&D, clinical trial, and commercialization programs anchored by Inje University and Baek Hospital in Gimhae.

Ownership category

akta.pro rank

Product category

Government Economic Zone / Life Sciences Industry Support

NAICS

Administration of General Economic Programs (92611), Scientific Research and Development Services (5417)

SIC

Services-Engineering, Accounting, Research, Management (8700), Services-Management Services (8741)

akta.pro primary industry

Economic Development & Business Licensing (Local) (BPAIACAN)

Keywords

• Life sciences incubation
• Bio industry support
• Medical technology commercialization
• Clinical trial services
• Special economic zone

Headquarters

HQ city

Gyeongsan

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Government-funded Economic Zone Operations: Operates as a government-designated special economic zone funded by public budget to promote regional life sciences industry development, technology commercialization, and job creation in the Gimhae region.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Gyeongnam Gimhae Special Economic Zone is a government-designated special economic zone that provides integrated support services for life sciences and medical technology companies. Its core offerings include innotech company cultivation and startup support programs, clinical trial and medical device demonstration services at Baek Hospital, technology commercialization support, and access to co-located R&D, manufacturing, and clinical facilities within a 1.13 km² designated area.

Product overview

Gyeongnam Gimhae Special Economic Zone (경남김해강소특구) is a government-designated special economic zone focused on developing Korea's bio/healthcare life sciences industry. The organization operates as a platform of interconnected zones and support services, including the R&D Convergence Zone at Inje University Baek Hospital for core technology development, the Technology Commercialization Zone in Golden Root Industrial Complex for startup support, and the Advanced Hub Zone in West Gimhae for enterprise scaling. The portfolio includes programs for innotech company discovery and startup support, clinical trial support and medical device demonstration, company introductions, excellent technology showcases, and newsletter services. The zone follows a 'BIG-DREAM Wellbio Medicluster' strategy (Brilliant Invention of Gimhae: Drug and Equipment for an Amazing Medicine, Wellbio Medicluster) targeting promising technology commercialization, one-stop clinical trial services, and OEM/external enterprise linkage for technology commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• innopolis: The brand name used for the Gyeongnam Gimhae Special Economic Zone website and branding, referring to the innovation hub concept.

Products and services

• Innotech Company Cultivation and Startup Support Program (강소특구 이노테크 기업 육성 사업) Program for innotech company cultivation and startup support in the bio/medical device sector, including technology commercialization demand discovery and analysis. Available to qualifying bio-medical companies and entrepreneurs applying to the zone.
• IU Clinical Support and Medical Device Demonstration Program (IU 임상지원 및 의료기기 실증 지원사업) One-stop clinical support and medical device demonstration program providing clinical trial center services at Baek Hospital, supporting medical technology validation for life sciences companies.
• Innotech Discovery and Startup Support Program (강소특구 이노테크 발굴 및 창업지원 사업) Support program for discovering innotech companies and supporting startup activities in the bio/medical device sector, including technology commercialization demand discovery and analysis.
• R&D Convergence Zone at Inje University Baek Hospital (R&D 융합지구) Core technology R&D zone centered at Inje University Baek Hospital, focusing on hospital-originated ideas, advanced R&D, technology IP accumulation, technology transfer induction, and joint corporate R&D. Available to life sciences companies operating within the zone.
• Technology Commercialization Zone (기술사업화지구) Technology commercialization zone in Golden Root Industrial Complex and Gimhae Life Sciences Center, supporting startup incubation, technology commercialization, and ecosystem development for bio-medical companies.
• Advanced Hub Zone (고도화 거점지구) Advanced hub zone in West Gimhae General Industrial Complex, promoting enterprise activation, factory establishment, and advanced medical technology development including precision medicine and convergent medical devices.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Inje University (인제대학교)coreStrategic or Co-development PartnerTechnical core institution and R&D convergence zone operator. Inje University serves as the central research and development hub of the Gyeongnam Gimhae Special Economic Zone, providing academic research capabilities, facilities, and expertise for life sciences technology development.
• Baek Hospital (백병원)coreStrategic or Co-development PartnerCore clinical research partner providing clinical trial center services and medical innovation capabilities. Supports technology development with clinical validation infrastructure and serves as the foundation for medical technology R&D within the zone.
• Golden Root Industrial Complex (골든루트일반산업단지)minorStrategic or Co-development PartnerTechnology commercialization district (Booster I) within the special economic zone providing manufacturing and production facilities for life sciences companies that have completed R&D and are ready for commercial production.
• Seogimhae General Industrial Complex (서김해일반산단)minorStrategic or Co-development PartnerHigh-tech enhancement hub district (Booster II) providing facilities for enterprise activation, factory establishment, and advanced medical technology development including precision medicine and convergence medical devices.
• Gimhae Life Sciences Center (김해의생명센터)minorStrategic or Co-development PartnerLife sciences facility within the technology commercialization district providing specialized infrastructure and support services for bio-medical companies operating in the zone.
• Gyeongsangnam-do Province (경상남도)coreOthersGoverning authority that designated and funds the Gyeongnam Gimhae Special Economic Zone. Provides administrative support, policy backing, and public funding for zone operations and company support programs.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Osong Bio Convergence Cluster: Korean government-designated bio convergence cluster in North Chungcheong Province focused on life sciences, pharmaceuticals, and medical devices. Directly comparable as a competing Korean national bio cluster with similar government backing, R&D-convergence-to-commercialization pipeline, and tenant recruitment model targeting the same domestic life sciences startups.
• Songdo Global Bio Cluster: Korean national bio cluster in Incheon Free Economic Zone focused on attracting global life sciences companies and biotech startups. Comparable as a government-supported bio innovation zone targeting the same industry vertical with R&D and commercialization support programs, but with much larger scale and stronger international positioning.
• Daegu-Gyeongbuk Advanced Medical Industry Promotion Foundation: Korean regional medical industry promotion foundation supporting medical device and healthcare innovation in the Daegu-Gyeongbuk region. Comparable as a government-backed regional cluster promoting life sciences startups with R&D support, clinical validation, and commercialization assistance, competing for the same Korean bio startup pool.
• Pangyo Techno Valley Bio Valley: Korean government-supported bio innovation cluster within Pangyo Techno Valley in Gyeonggi Province. Comparable as a government-backed bio cluster focused on life sciences, biotech, and medical devices with similar tenant incubation and technology commercialization support programs targeting Korean life sciences companies.
• Osong Medical Innovation Foundation: Korean biohealth-focused foundation supporting medical device innovation, clinical trials, and regulatory approval. Comparable as a Korea-based organization providing one-stop clinical trial and commercialization support for life sciences startups, directly competing for the same domestic bio startup tenant base.

Broad incumbents

• Biopolis (Singapore): Singapore's government-designated biomedical research hub managed by A*STAR, integrating public research institutes, clinical infrastructure, and bio companies. Comparable as a government-backed life sciences cluster with integrated R&D-clinical-commercialization pipeline, but operating at national scale and with significantly more international reach than the Gimhae zone.
• Research Triangle Park (RTP): Large US research park in North Carolina hosting life sciences, biotech, and medical device companies alongside university research infrastructure. Comparable as a multi-tenant life sciences cluster with co-located university R&D and clinical facilities, but operating at vastly larger scale (7,000+ acres) and with private-sector management rather than government ownership.

Others

• Catalent Pharma Solutions Korea: Global contract development and manufacturing organization (CDMO) supporting pharmaceutical and biotech companies with clinical trial services and commercial manufacturing. Comparable as a provider of OEM/contract manufacturing and clinical trial support services that the Gimhae zone's participating life sciences companies could engage as ecosystem partners, though operating as a private commercial entity rather than a government zone.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xtwitter.com/G_innopolis
• YouTubeyoutube.com/channel/UCqGZ8u_AZVwkp3BP-me3Wtw
• Facebookfacebook.com/100064153290456

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gyeongnam Gimhae Special Economic Zone